Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc lowers Q4 2013 revenue guidance; gives Q1, FY 2014 guidance in line with analysts' estimates


Monday, 13 Jan 2014 07:30am EST 

Natus Medical Inc:Sees FY 2014 revenue of $345 million to $350 million.Sees FY 2014 non-GAAP earnings per share of $1.12 to $1.16.Sees Q1 2014 revenue of $82 million to $86 million.Sees Q1 2014 Non-GAAP earnings per share of $0.21 to $0.24.Sees Q4 2013 revenue of about $90.0 to $90.5 million.FY 2014 revenues of $347 million and EPS of $1.12 - Thomson Reuters I/B/E/S Estimates.Q1 2014 revenues of $85 million and EPS of $0.24 - Thomson Reuters I/B/E/S Estimates. 

Company Quote

28.52
-0.99 -3.35%
1 Oct 2014